Brief, interoceptive exposure focused treatment for anxiety in mild cognitive impairment

Anxiety is common in older adults with mild cognitive impairment (MCI), and Alzheimer's disease and related dementias (ADRD). Anxiety has also been identified as a risk factor for cognitive decline. Brief interventions targeting risk mechanisms of anxiety, such as anxiety sensitivity (AS), have...

Full description

Saved in:
Bibliographic Details
Published in:Age and ageing 2022-06, Vol.51 (6)
Main Authors: Schmidt, Norman B, Schubert, Frederick T, Sheffler, Julia L
Format: Article
Language:English
Subjects:
Aged
Alzheimer Disease
Alzheimer's disease
Anxiety
Anxiety - diagnosis
Anxiety - therapy
Brief interventions
Cognitive ability
Cognitive Dysfunction - diagnosis
Cognitive Dysfunction - therapy
Cognitive impairment
Efficacy
Feasibility
Humans
Neurodegenerative diseases
Older people
Risk factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c397t-6e27f5e36d31cdfb3d1363360c38d2bcf8184fe8d4d64d1126c8318873d621253
cites cdi_FETCH-LOGICAL-c397t-6e27f5e36d31cdfb3d1363360c38d2bcf8184fe8d4d64d1126c8318873d621253
container_end_page
container_issue 6
container_start_page
container_title Age and ageing
container_volume 51
creator Schmidt, Norman B
Schubert, Frederick T
Sheffler, Julia L
description Anxiety is common in older adults with mild cognitive impairment (MCI), and Alzheimer's disease and related dementias (ADRD). Anxiety has also been identified as a risk factor for cognitive decline. Brief interventions targeting risk mechanisms of anxiety, such as anxiety sensitivity (AS), have been effective in reducing overall anxiety in a variety of populations. This case series investigated the feasibility and efficacy of a brief AS intervention in anxious older adults with MCI (n = 9). Paired samples t-test results indicate that this intervention is capable of significantly reducing AS as measured by the Anxiety Sensitivity Index-3 (Δ = 5.11, Hedges g = 0.82, P 
doi_str_mv 10.1093/ageing/afac133
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2676552445</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2677263088</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-6e27f5e36d31cdfb3d1363360c38d2bcf8184fe8d4d64d1126c8318873d621253</originalsourceid><addsrcrecordid>eNpdkE1LAzEQhoMotlavHmXBiwe3TTK72fSoxS8oeFHwtqTJpKTsl8mutP_eXVs9eBpmeN6X4SHkktEpo3OYqTW6aj1TVmkGcETGLBEy5hKSYzKmlPKYZnw-ImchbPqVpYyfkhGkYp5BCmPyce8d2tvIVS36WmPTui-McNvUofMY2Vp3AU3UelRtiVXbX3ykqq3DdteHotIVJtL1unI_QVc2yvkBPCcnVhUBLw5zQt4fH94Wz_Hy9ellcbeMNcyzNhbIM5siCANMG7sCw0AACKpBGr7SVjKZWJQmMSIxjHGhJTApMzCCM57ChNzsextff3YY2rx0QWNRqArrLuRcZCJNeZIM6PU_dFN3vuq_G6iMC6BS9tR0T2lfh-DR5o13pfK7nNF8cJ7vnecH533g6lDbrUo0f_ivZPgGhih_Lw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2677263088</pqid></control><display><type>article</type><title>Brief, interoceptive exposure focused treatment for anxiety in mild cognitive impairment</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Oxford Journals Online</source><creator>Schmidt, Norman B ; Schubert, Frederick T ; Sheffler, Julia L</creator><creatorcontrib>Schmidt, Norman B ; Schubert, Frederick T ; Sheffler, Julia L</creatorcontrib><description>Anxiety is common in older adults with mild cognitive impairment (MCI), and Alzheimer's disease and related dementias (ADRD). Anxiety has also been identified as a risk factor for cognitive decline. Brief interventions targeting risk mechanisms of anxiety, such as anxiety sensitivity (AS), have been effective in reducing overall anxiety in a variety of populations. This case series investigated the feasibility and efficacy of a brief AS intervention in anxious older adults with MCI (n = 9). Paired samples t-test results indicate that this intervention is capable of significantly reducing AS as measured by the Anxiety Sensitivity Index-3 (Δ = 5.11, Hedges g = 0.82, P &lt; 0.05). Given these large AS reductions and high acceptability, further investigation of this intervention is warranted in older adults with MCI.</description><identifier>ISSN: 0002-0729</identifier><identifier>EISSN: 1468-2834</identifier><identifier>DOI: 10.1093/ageing/afac133</identifier><identifier>PMID: 35697353</identifier><language>eng</language><publisher>England: Oxford Publishing Limited (England)</publisher><subject>Aged ; Alzheimer Disease ; Alzheimer's disease ; Anxiety ; Anxiety - diagnosis ; Anxiety - therapy ; Brief interventions ; Cognitive ability ; Cognitive Dysfunction - diagnosis ; Cognitive Dysfunction - therapy ; Cognitive impairment ; Efficacy ; Feasibility ; Humans ; Neurodegenerative diseases ; Older people ; Risk factors</subject><ispartof>Age and ageing, 2022-06, Vol.51 (6)</ispartof><rights>The Author(s) 2022. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-6e27f5e36d31cdfb3d1363360c38d2bcf8184fe8d4d64d1126c8318873d621253</citedby><cites>FETCH-LOGICAL-c397t-6e27f5e36d31cdfb3d1363360c38d2bcf8184fe8d4d64d1126c8318873d621253</cites><orcidid>0000-0002-9784-1134 ; 0000-0001-8686-5416</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906,30980</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35697353$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schmidt, Norman B</creatorcontrib><creatorcontrib>Schubert, Frederick T</creatorcontrib><creatorcontrib>Sheffler, Julia L</creatorcontrib><title>Brief, interoceptive exposure focused treatment for anxiety in mild cognitive impairment</title><title>Age and ageing</title><addtitle>Age Ageing</addtitle><description>Anxiety is common in older adults with mild cognitive impairment (MCI), and Alzheimer's disease and related dementias (ADRD). Anxiety has also been identified as a risk factor for cognitive decline. Brief interventions targeting risk mechanisms of anxiety, such as anxiety sensitivity (AS), have been effective in reducing overall anxiety in a variety of populations. This case series investigated the feasibility and efficacy of a brief AS intervention in anxious older adults with MCI (n = 9). Paired samples t-test results indicate that this intervention is capable of significantly reducing AS as measured by the Anxiety Sensitivity Index-3 (Δ = 5.11, Hedges g = 0.82, P &lt; 0.05). Given these large AS reductions and high acceptability, further investigation of this intervention is warranted in older adults with MCI.</description><subject>Aged</subject><subject>Alzheimer Disease</subject><subject>Alzheimer's disease</subject><subject>Anxiety</subject><subject>Anxiety - diagnosis</subject><subject>Anxiety - therapy</subject><subject>Brief interventions</subject><subject>Cognitive ability</subject><subject>Cognitive Dysfunction - diagnosis</subject><subject>Cognitive Dysfunction - therapy</subject><subject>Cognitive impairment</subject><subject>Efficacy</subject><subject>Feasibility</subject><subject>Humans</subject><subject>Neurodegenerative diseases</subject><subject>Older people</subject><subject>Risk factors</subject><issn>0002-0729</issn><issn>1468-2834</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNpdkE1LAzEQhoMotlavHmXBiwe3TTK72fSoxS8oeFHwtqTJpKTsl8mutP_eXVs9eBpmeN6X4SHkktEpo3OYqTW6aj1TVmkGcETGLBEy5hKSYzKmlPKYZnw-ImchbPqVpYyfkhGkYp5BCmPyce8d2tvIVS36WmPTui-McNvUofMY2Vp3AU3UelRtiVXbX3ykqq3DdteHotIVJtL1unI_QVc2yvkBPCcnVhUBLw5zQt4fH94Wz_Hy9ellcbeMNcyzNhbIM5siCANMG7sCw0AACKpBGr7SVjKZWJQmMSIxjHGhJTApMzCCM57ChNzsextff3YY2rx0QWNRqArrLuRcZCJNeZIM6PU_dFN3vuq_G6iMC6BS9tR0T2lfh-DR5o13pfK7nNF8cJ7vnecH533g6lDbrUo0f_ivZPgGhih_Lw</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Schmidt, Norman B</creator><creator>Schubert, Frederick T</creator><creator>Sheffler, Julia L</creator><general>Oxford Publishing Limited (England)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9784-1134</orcidid><orcidid>https://orcid.org/0000-0001-8686-5416</orcidid></search><sort><creationdate>20220601</creationdate><title>Brief, interoceptive exposure focused treatment for anxiety in mild cognitive impairment</title><author>Schmidt, Norman B ; Schubert, Frederick T ; Sheffler, Julia L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-6e27f5e36d31cdfb3d1363360c38d2bcf8184fe8d4d64d1126c8318873d621253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aged</topic><topic>Alzheimer Disease</topic><topic>Alzheimer's disease</topic><topic>Anxiety</topic><topic>Anxiety - diagnosis</topic><topic>Anxiety - therapy</topic><topic>Brief interventions</topic><topic>Cognitive ability</topic><topic>Cognitive Dysfunction - diagnosis</topic><topic>Cognitive Dysfunction - therapy</topic><topic>Cognitive impairment</topic><topic>Efficacy</topic><topic>Feasibility</topic><topic>Humans</topic><topic>Neurodegenerative diseases</topic><topic>Older people</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schmidt, Norman B</creatorcontrib><creatorcontrib>Schubert, Frederick T</creatorcontrib><creatorcontrib>Sheffler, Julia L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Age and ageing</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schmidt, Norman B</au><au>Schubert, Frederick T</au><au>Sheffler, Julia L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Brief, interoceptive exposure focused treatment for anxiety in mild cognitive impairment</atitle><jtitle>Age and ageing</jtitle><addtitle>Age Ageing</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>51</volume><issue>6</issue><issn>0002-0729</issn><eissn>1468-2834</eissn><abstract>Anxiety is common in older adults with mild cognitive impairment (MCI), and Alzheimer's disease and related dementias (ADRD). Anxiety has also been identified as a risk factor for cognitive decline. Brief interventions targeting risk mechanisms of anxiety, such as anxiety sensitivity (AS), have been effective in reducing overall anxiety in a variety of populations. This case series investigated the feasibility and efficacy of a brief AS intervention in anxious older adults with MCI (n = 9). Paired samples t-test results indicate that this intervention is capable of significantly reducing AS as measured by the Anxiety Sensitivity Index-3 (Δ = 5.11, Hedges g = 0.82, P &lt; 0.05). Given these large AS reductions and high acceptability, further investigation of this intervention is warranted in older adults with MCI.</abstract><cop>England</cop><pub>Oxford Publishing Limited (England)</pub><pmid>35697353</pmid><doi>10.1093/ageing/afac133</doi><orcidid>https://orcid.org/0000-0002-9784-1134</orcidid><orcidid>https://orcid.org/0000-0001-8686-5416</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-0729
ispartof Age and ageing, 2022-06, Vol.51 (6)
issn 0002-0729
1468-2834
language eng
recordid cdi_proquest_miscellaneous_2676552445
source Applied Social Sciences Index & Abstracts (ASSIA); Oxford Journals Online
subjects Aged
Alzheimer Disease
Alzheimer's disease
Anxiety
Anxiety - diagnosis
Anxiety - therapy
Brief interventions
Cognitive ability
Cognitive Dysfunction - diagnosis
Cognitive Dysfunction - therapy
Cognitive impairment
Efficacy
Feasibility
Humans
Neurodegenerative diseases
Older people
Risk factors
title Brief, interoceptive exposure focused treatment for anxiety in mild cognitive impairment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T01%3A03%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Brief,%20interoceptive%20exposure%20focused%20treatment%20for%20anxiety%20in%20mild%20cognitive%20impairment&rft.jtitle=Age%20and%20ageing&rft.au=Schmidt,%20Norman%20B&rft.date=2022-06-01&rft.volume=51&rft.issue=6&rft.issn=0002-0729&rft.eissn=1468-2834&rft_id=info:doi/10.1093/ageing/afac133&rft_dat=%3Cproquest_cross%3E2677263088%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c397t-6e27f5e36d31cdfb3d1363360c38d2bcf8184fe8d4d64d1126c8318873d621253%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2677263088&rft_id=info:pmid/35697353&rfr_iscdi=true